# Autologous CARTmeso/19 Against Pancreatic Cancer

> **NCT03497819** · EARLY_PHASE1 · UNKNOWN · sponsor: **First Affiliated Hospital of Wenzhou Medical University** · enrollment: 10 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **BIOLOGICAL:** CARTmeso CART19

## Key facts

- **NCT ID:** NCT03497819
- **Lead sponsor:** First Affiliated Hospital of Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-01
- **Primary completion:** 2019-10-31
- **Final completion:** 2020-10-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2018-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03497819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03497819, "Autologous CARTmeso/19 Against Pancreatic Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03497819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*